Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Legend Biotech
Legend Biotech
J&J, Legend cell therapy approved by FDA for multiple myeloma
BioPharma Dive
Mon, 02/28/22 - 11:44 pm
JNJ
Legend Biotech
FDA
Multiple Myeloma
Carvykti
CAR-T
Legend's early-stage CAR-T on FDA hold after single patient dosed
Fierce Biotech
Tue, 02/15/22 - 10:15 am
Legend Biotech
CAR-T
FDA
clinical trials
clinical hold
LB1901
Go or no go? PDUFA resolutions eyed for J&J and Amryt
EP Vantage
Wed, 01/26/22 - 10:40 am
FDA
JNJ
Legend Biotech
ciltacabtagene autoleucel
Amryt
Oleogel-S10
JPM22, Day 3: In short order, Perrigo part of a new landscape; Legend, J&J prep for cilta-cel launch
Fierce Pharma
Wed, 01/12/22 - 11:22 pm
JPMHC 2022
Bausch Health
Amgen
Eli Lilly
Perrigo
JNJ
Legend Biotech
Why Legend Biotech Shares Plummeted 17.6% Wednesday
Motley Fool
Wed, 12/15/21 - 11:47 pm
Legend Biotech
CAR-T
cancer
FDA pushes back decision on J&J, Legend's BCMA CAR-T
Endpoints
Tue, 11/2/21 - 10:42 am
JNJ
Legend Biotech
FDA
CAR-T
cilta-cel
Will This 2020 Biotech IPO Crush the Market This Year?
Motley Fool
Tue, 06/29/21 - 10:57 am
Legend Biotech
IPOs
Multiple Myeloma
Legend Biotech and Janssen establish Belgium cell therapy site
Biopharma Reporter
Mon, 06/28/21 - 10:47 am
Legend Biotech
Janssen
Belgium
cell therapy
Bristol Myers, bluebird bio have their BCMA CAR-T nod, but latecomer J&J could have an advantage: analysts
Fierce Pharma
Mon, 03/29/21 - 10:55 pm
Bristol Myers Squibb
Bluebird Bio
CAR-T
JNJ
Legend Biotech
Abecma
Plot thickens around Legend Biotech, GenScript with founder Frank Zhang's arrest
Endpoints
Mon, 11/23/20 - 10:34 am
Legend Biotech
Frank Zhang
Legend Biotech has a new chairwoman and permanent CEO. But where is Frank Zhang?
Endpoints
Mon, 11/9/20 - 11:04 am
Legend Biotech
Frank Zhang
Sally Wang
Pharma CEOs
Legend Biotech sinks today as CEO Zhang is under a customs investigation
Motley Fool
Mon, 09/21/20 - 10:36 am
Legend Biotech
GenScript
Frank Zhang
customs
Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech's biggest IPO of 2020
BioPharma Dive
Fri, 06/5/20 - 11:02 am
Legend Biotech
IPOs
cancer
cell therapies
ASCO 2020
Biotech IPOs near last year's pace, despite COVID-19 pandemic
BioPharma Dive
Wed, 06/3/20 - 11:28 pm
IPOs
biotech
Pliant Therapeutics
Legend Biotech
Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action
Fierce Biotech
Mon, 06/1/20 - 10:56 am
Legend Biotech
IPOs
GenScript
NASDAQ
Biotech J&J-backed CAR-T biotech Legend guns for $100M IPO but sees CRS death in early trial
Fierce Biotech
Thu, 05/14/20 - 10:23 am
IPOs
Legend Biotech
cell therapy
NASDAQ
China
Eyeing a fast pitch for quick OK in race with bluebird, J&J/Legend team enjoys a regulatory embrace for their rival BCMA CAR-T
Endpoints
Thu, 04/4/19 - 11:53 am
JNJ
Legend Biotech
JNJ-68284528
CAR-T
BCMA
ASH18: Legend's CAR-T brought back to reality
Biopharma Dive
Mon, 12/3/18 - 10:53 pm
Legend Biotech
ASH 2018
CAR-T
Multiple Myeloma
J&J hustles Legend’s promising BCMA CAR-T into PhI/II trial, winning an FDA green light to begin recruiting patients
Endpoints
Wed, 05/30/18 - 08:34 pm
Legend Biotech
CAR-T
LCAR-B38M
Multiple Myeloma
J&J wows with a $350M cash deal to partner on CAR-T with Legend, a one-time unknown until its star turn at ASCO
Endpoints
Thu, 12/21/17 - 10:38 pm
JNJ
CAR-T
Legend Biotech
LCAR-B38M
BCMA
China
Pages
« first
‹ previous
1
2